Correlation Between ESSA Pharma and Traws Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ESSA Pharma and Traws Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ESSA Pharma and Traws Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ESSA Pharma and Traws Pharma, you can compare the effects of market volatilities on ESSA Pharma and Traws Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ESSA Pharma with a short position of Traws Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of ESSA Pharma and Traws Pharma.

Diversification Opportunities for ESSA Pharma and Traws Pharma

-0.27
  Correlation Coefficient

Very good diversification

The 3 months correlation between ESSA and Traws is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding ESSA Pharma and Traws Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Traws Pharma and ESSA Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ESSA Pharma are associated (or correlated) with Traws Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Traws Pharma has no effect on the direction of ESSA Pharma i.e., ESSA Pharma and Traws Pharma go up and down completely randomly.

Pair Corralation between ESSA Pharma and Traws Pharma

Given the investment horizon of 90 days ESSA Pharma is expected to generate 0.66 times more return on investment than Traws Pharma. However, ESSA Pharma is 1.53 times less risky than Traws Pharma. It trades about 0.02 of its potential returns per unit of risk. Traws Pharma is currently generating about 0.01 per unit of risk. If you would invest  273.00  in ESSA Pharma on October 12, 2024 and sell it today you would lose (99.00) from holding ESSA Pharma or give up 36.26% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

ESSA Pharma  vs.  Traws Pharma

 Performance 
       Timeline  
ESSA Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ESSA Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Traws Pharma 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Traws Pharma are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Traws Pharma showed solid returns over the last few months and may actually be approaching a breakup point.

ESSA Pharma and Traws Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ESSA Pharma and Traws Pharma

The main advantage of trading using opposite ESSA Pharma and Traws Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ESSA Pharma position performs unexpectedly, Traws Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Traws Pharma will offset losses from the drop in Traws Pharma's long position.
The idea behind ESSA Pharma and Traws Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios